Use of systemic beta blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers was not different between patients with wet and dry age-related macular degeneration. Medscape Medical News
Secondary IOL may treat refractive errors after keratoplasty
A supplementary sulcus-fixated IOL may help reduce spherical and astigmatic refractive errors in pseudophakic eyes that underwent keratoplasty, according to a study.The retrospective study reviewed 10 pseudophakic post-keratoplasty eyes after implantat…
VIDEO: Speaker discusses strategies for treating patients with ocular trauma
NICE, France — At the Euretina meeting, Sundaram Natarajan, MD, gives highlights from the symposium, Newer Strategies in Ocular Trauma. The lesson to learn from current approaches is that proactive intervention is essential and that primary wound repair should be attempted followed by further management by the vitreoretinal specialist.
Leading ophthalmologists present real world clinical outcomes on Oraya Therapy for wet AMD
Oraya Therapeutics Inc. has announced that leading ophthalmologists from three European countries presented patient results following one year after a single treatment with Oraya Therapy for wet…
InnFocus completes $32.8 million financing for MicroShunt system
InnFocus completed a $32.8 million Series C financing to fund the study of its MicroShunt glaucoma drainage system, according to a press release.The financing, which includes investors Hoya Corporation, Saints Capital Everest, Santen Pharmaceutical and Crown Venture Fund, will fund the system’s final phase of clinical trials.
Teach Patients How to Communicate Symptoms Better
(MedPage Today) — Patients should learn the eight characteristics of a symptom